Treatment persistence, hypoglycaemia and clinical outcomes in type 2 diabetes patients with dipeptidyl peptidase-4 inhibitors and sulphonylureas: a primary care database analysis
Diabetes, obesity & metabolism | 7 Aug 2012
W Rathmann, K Kostev, JB Gruenberger, M Dworak, G Bader and G Giani
To investigate therapy persistence, frequency of hypoglycaemia and macrovascular outcomes among type 2 diabetes patients with dipeptidyl peptidase-4 (DPP-4) inhibitors (DPP-4) and sulphonylureas (SU).
* Data courtesy of Altmetric.com